Andrea Z.
- Country
- Italy
- Department
- Centro Ricerche Cliniche di Verona S.r.l.
Research Overview
- Evaluation of KO-2806 as Monotherapy and in Combination Therapies for Advanced Colorectal, NSCLC, Pancreatic, and Renal Cell Carcinomas
- Phase I Evaluation of NI-1801 Monotherapy and Combination with Anti-PD-1 or Paclitaxel in Advanced Mesothelin-Expressing Solid Tumors
- Evaluation of [Main Substance] in Combination with Other Agents in Patients with Advanced Solid Tumors
Data & Insights
Has run more than one trial at 292 of 511 partner sites.
Specializations
Urological Oncology
Extensive involvement in clinical research targeting various types of urological cancers, with particular focus on bladder cancer treatment modalities and prostate cancer therapeutics.
- Muscle-invasive bladder cancer treatments
- Advanced urothelial carcinoma therapies
- Metastatic prostate cancer interventions
Special emphasis on combination immunotherapy approaches and novel targeted treatments for bladder cancer.
Advanced Solid Tumors
Broad expertise in treating multiple types of advanced solid malignancies, including innovative approaches for various cancer types.
- Head and neck squamous cell carcinoma
- Renal cell carcinoma
- Ovarian cancer
Focus on developing personalized treatment strategies and novel therapeutic combinations.
Immunotherapy Research
Leading investigations into innovative immunotherapy approaches and combination treatments for multiple cancer types.
- Checkpoint inhibitor combinations
- Novel antibody-drug conjugates
- Targeted therapy combinations
Particular interest in immunotherapy applications for genitourinary cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.